Stockholders' Equity - Summary of Additional Stock Option Disclosures (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Options Outstanding, Weighted Average Remaining Contractual Term	5 years 6 months
Options Exercisable, Weighted Average Remaining Contractual Term	5 years 1 month 6 days
Options Outstanding, Intrinsic Value	$ 33,087
Options Exercisable, Intrinsic Value	$ 28,906
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 16.41	$ 12.14	$ 11.55
Options, Exercised in Period, Aggregate Intrinsic Value	$ 8,860	$ 1,822	$ 4,269
Options, Vested in Period, Fair Value	2,020	3,384	2,446
Options, Exercised in Period, Proceeds from Issuance of Shares	8,186	4,091	1,082
Options Exercised, Tax Benefit	$ 2,215	$ 455	$ 1,067